全文获取类型
收费全文 | 10933篇 |
免费 | 682篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 167篇 |
儿科学 | 406篇 |
妇产科学 | 399篇 |
基础医学 | 1029篇 |
口腔科学 | 355篇 |
临床医学 | 805篇 |
内科学 | 2286篇 |
皮肤病学 | 193篇 |
神经病学 | 548篇 |
特种医学 | 386篇 |
外科学 | 2193篇 |
综合类 | 350篇 |
一般理论 | 12篇 |
预防医学 | 681篇 |
眼科学 | 257篇 |
药学 | 888篇 |
中国医学 | 73篇 |
肿瘤学 | 655篇 |
出版年
2023年 | 105篇 |
2022年 | 121篇 |
2021年 | 359篇 |
2020年 | 277篇 |
2019年 | 363篇 |
2018年 | 462篇 |
2017年 | 277篇 |
2016年 | 363篇 |
2015年 | 380篇 |
2014年 | 507篇 |
2013年 | 658篇 |
2012年 | 910篇 |
2011年 | 863篇 |
2010年 | 492篇 |
2009年 | 382篇 |
2008年 | 612篇 |
2007年 | 675篇 |
2006年 | 626篇 |
2005年 | 546篇 |
2004年 | 482篇 |
2003年 | 406篇 |
2002年 | 384篇 |
2001年 | 129篇 |
2000年 | 114篇 |
1999年 | 101篇 |
1998年 | 61篇 |
1997年 | 46篇 |
1996年 | 37篇 |
1995年 | 34篇 |
1994年 | 41篇 |
1993年 | 28篇 |
1992年 | 87篇 |
1991年 | 52篇 |
1990年 | 66篇 |
1989年 | 58篇 |
1988年 | 43篇 |
1987年 | 48篇 |
1986年 | 24篇 |
1985年 | 43篇 |
1984年 | 30篇 |
1983年 | 37篇 |
1982年 | 20篇 |
1980年 | 19篇 |
1979年 | 32篇 |
1978年 | 20篇 |
1977年 | 26篇 |
1976年 | 18篇 |
1974年 | 34篇 |
1973年 | 33篇 |
1972年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Ibrahim Aldoss MD Salman Otoukesh MD Jianying Zhang PhD Sally Mokhtari PhD Dat Ngo PharmD Mona Mojtahedzadeh MD Monzr M. Al Malki MD Amandeep Salhotra MD Haris Ali MD Ahmed Aribi MD Karamjeet S. Sandhu MD Shukaib Arslan MD Paul Koller MD Brian Ball MD Forrest Stewart MD Peter Curtin MD Andrew Artz MD Ryotaro Nakamura MD Guido Marcucci MD Stephen J. Forman MD Anthony S. Stein MD Vinod Pullarkat MD 《Cancer》2022,128(3):529-535
3.
Weidner Kathrin Behnes Michael Schupp Tobias Hoppner Jorge Ansari Uzair Mueller Julian Lindner Simon Borggrefe Martin Kim Seung-hyun Huseyinov Aydin Ellguth Dominik Akin Muharrem Meininghaus Dirk Große Bertsch Thomas Taton Gabriel Bollow Armin Reichelt Thomas Engelke Niko Reiser Linda Akin Ibrahim 《Journal of interventional cardiac electrophysiology》2022,63(1):13-20
Journal of Interventional Cardiac Electrophysiology - The study sought to assess the prognostic impact of chronic kidney disease (CKD) in patients with electrical storm (ES). ES represents a... 相似文献
4.
Evaluation of KISS1 Receptor Gene Expression in Egyptian Female Patients with Breast Cancer 下载免费PDF全文
Salwa Hamdi GomaaMoyassar Ahmed ZakiMohamed Hussein SultanFatma Ibrahim DwedarEman Hassan Elzain Zidan 《Asian Pacific journal of cancer prevention》2022,23(3):961-969
Objective: Breast cancer is the second most common cancer in the world. Many metastasis suppressor genes were identified, including the KISS1 gene which encodes for a 145 amino acid protein (kisspeptin-145), which undergoes proteolytic cleavage resulting in kisspeptin-14, -13 and -10. All of these proteins can activate KISS1 receptor (KISS1R). The role of KP/KISS1R signaling in breast cancer remains controversial. The present study aimed to measure mRNA gene expression of KISS1 receptor in healthy and cancerous breast tissue and to evaluate the association of its level with the available molecular subtypes and the traditional clinico-pathological variables. Methods: The study was done on 41 operable primary breast cancer patients. Biopsies from both tumor tissue and surrounding healthy mammary tissue were taken from all patients. KISS1R mRNA expression level was measured using a quantitative real time PCR. Results: KISS1R mRNA expression was significantly higher in stage III patients compared to stage II patients. At a cut-off value for KISS1R mRNA expression of 1.75, stage II was discriminated from stage III. A significant positive correlation was found between KISS1R mRNA expression and tumor size as well as lymph nodes metastasis. KISS1R mRNA was highly expressed in ER negative cases compared to ER positive ones, and in PR negative cases compared to PR positive ones. There was a statistically significant difference in KISS1R mRNA expression levels and different molecular subtypes being over-expressed in HER2 and triple negative cancer cases. Conclusion: This study supports other studies suggesting that KISS1/KISS1R may not be acting as a metastasis suppressor in breast cancer. KISS1R mRNA is over expressed in advanced stages of breast cancer and hence it can be used as a prognostic marker for aggressiveness of breast cancer. Also being over expressed in triple negative patients, KISS1R could represent a promising therapeutic target in triple negative cases. 相似文献
5.
Sami Akbulut Abdirahman Sakulen Hargura Ibrahim Umar Garzali Ali Aloun Cemil Colak 《World Journal of Clinical Cases》2022,10(26):9228-9240
Management of colorectal cancer (CRC) was severely affected by the changes implemented during the pandemic, and this resulted in delayed elective presentation, increased emergency presentation, reduced screening and delayed definitive therapy. This review was conducted to analyze the impact of the coronavirus disease 2019 (COVID-19) pandemic on management of CRC and to identify the changes made in order to adapt to the pandemic. We performed a literature search in PubMed, Medline, Index Medicus, EMBASE, SCOPUS, Reference Citation Analysis (https://www.referencecitationanalysis.com/) and Google Scholar using the following keywords in various combinations: Colorectal cancer, elective surgery, emergency surgery, stage upgrading, screening, surveillance and the COVID-19 pandemic. Only studies published in English were included. To curtail the spread of COVID-19 infection, there were modifications made in the management of CRC. Screening was limited to high risk individuals, and the screening tests of choice during the pandemic were fecal occult blood test, fecal immunochemical test and stool DNA testing. The use of capsule colonoscopy and open access colonoscopy was also encouraged. Blood-based tests like serum methylated septin 9 were also encouraged for screening of CRC during the pandemic. The presentation of CRC was also affected by the pandemic with more patients presenting with emergencies like obstruction and perforation. Stage migration was also observed during the pandemic with more patients presenting with more advanced tumors. The operative therapy of CRC was altered by the pandemic as more emergencies surgeries were done, which may require exteriorization by stoma. This was to reduce the morbidity associated with anastomosis and encourage early discharge from the hospital. There was also an initial reduction in laparoscopic surgical procedures due to the fear of aerosols and COVID-19 infection. As we gradually come out of the pandemic, we should remember the lessons learned and continue to apply them even after the pandemic passes. 相似文献
6.
Helmer Philipp Schlesinger Tobias Hottenrott Sebastian Papsdorf Michael Wöckel Achim Diessner Joachim Stumpner Jan Sitter Magdalena Skazel Tobias Wurmb Thomas Härtel Christoph Hofer Stefan Alkatout Ibrahim Girard Thierry Meybohm Patrick Kranke Peter 《Der Anaesthesist》2022,71(3):171-180
Die Anaesthesiologie - Die Implementierung eines Patient Blood Management (PBM) wird zunehmender Standard in der operativen Medizin. Seit einiger Zeit gilt das Interesse auch den vulnerablen... 相似文献
7.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
8.
9.
Reginia Nabil Guirguis Ehab Hasan Nashaat Azza Emam Yassin Wesam Ahmed Ibrahim Shereen A Saleh Mohamed Bahaa Mahmoud El-Meteini Mohamed Fathy Hany Mansour Dabbous Iman Fawzy Montasser Manar Salah Ghada Abdelrahman Mohamed 《World journal of hepatology》2021,13(10):1405-1416
BACKGROUND Despite significant advancements in liver transplantation(LT) surgical procedures and perioperative care, post-LT biliary complications(BCs) remain a significant source of morbidity, mortality, and graft failure. In addition, data are conflicting regarding the health-related quality of life(HRQoL) of LT recipients. Thus, the success of LT should be considered in terms of both the survival and recovery of HRQoL.AIM To assess the impact of BCs on the HRQoL of live-donor LT recipients(LDLT-Rs).METHODS We retrospectively analysed data for 25 LDLT-Rs who developed BCs post-LT between January 2011 and December 2016 at our institution. The Short Form 12 version 2(SF 12 v2) health survey was used to assess their HRQoL. We also included 25 LDLT-Rs without any post-LT complications as a control group.RESULTS The scores for HRQoL of LDLT-Rs who developed BCs were significantly higher than the norm-based scores in the domains of physical functioning(P = 0.003),role-physical(P 0.001), bodily pain(P = 0.003), general health(P = 0.004), social functioning(P = 0.005), role-emotional(P 0.001), and mental health(P 0.001). No significant difference between the two groups regarding vitality was detected(P = 1.000). The LDLT-Rs with BCs had significantly lower scores than LDLT-Rs without BCs in all HRQoL domains(P 0.001) and the mental(P 0.001) and physical(P = 0.0002) component summary scores.CONCLUSION The development of BCs in LDLT-Rs causes a lower range of improvement in HRQoL. 相似文献
10.
Khalid Ibrahim Bzeizi Richard Smith Ali Albenmousa Madhukar Dama Faisal Aba-Alkhail Rajiv Jalan Dieter Broering 《Transplantation proceedings》2021,53(1):148-158
BackgroundRisk of nephrotoxicity in liver transplant patients on calcineurin inhibitors (CnIs) is a concern. Several controlled trials reported benefit of everolimus (EVR) in minimizing this risk when combined with a reduced CnI dose.BackgroundTo systematically review the efficacy and safety of EVR, alone or with reduced CnI dose, as compared to CnI alone post-liver transplantation.MethodsWe searched MEDLINE, Scopus, and the Cochrane Library for randomized controlled trials comparing EVR- and CnI-based regimens post-liver transplantation. Assessment of studies and data extraction were undertaken independently.ResultsEight studies were selected, describing 769 patients. Cockcroft-Gault GFR was higher at one (P = .05), 3, and 5 years (P = .030) in patients on EVR compared to those receiving CnI therapy. The composite endpoint of efficacy failure was similar between the 2 arms after 1, 3, and 5 years of study. More patients discontinued EVR due to adverse effects in 1 year; however, no difference was noted after 3 or 5 years. A higher rates of proteinuria, peripheral edema, and incisional hernia occurred in patients on EVR.ConclusionsThe analysis confirms noninferiority of EVR and reduced CnI combination. Combination regimen resulted in better renal function compared to standard CnI therapy. 相似文献